Purified feline leukemia virus, UV lightinactivated feline leukemia virus, and a synthetic peptide (CKS-17) homologous to a well-conserved region of the transmembrane components of several human and animal retroviruses were each studied for their effects on IgG production by feline peripheral blood lymphocytes. Using a reverse hemolytic plaque assay, both the viable virus and the UV-inactivated feline leukemia virus, but not the CKS-17, activated B lymphocytes to secrete IgG. When staphylococcal protein A, a polyclonal B-cell activator, was used to stimulate IgG synthesis by feline lymphocytes, the viable virus, the UV-inactivated virus, and the CKS-17 peptide each strongly suppressed IgG secretion without compromising viability of the lymphocytes. These findings suggest that the immunosuppressive influences of feline leukemia virus on immunoglobulin synthesis may reside in a conserved portion of the envelope glycoprotein that includes the region homologous to CKS-17.
Many oncogenic human and animal retroviruses, including feline leukemia virus (FeLV), exert profound immunosuppressive effects on their hosts (1-6), leading to enhanced susceptibility to infections by opportunistic organisms. Of special concern are the immunosuppressive influences of human T-lymphotropic virus type III/lymphadenopathyassociated virus [HTLV-III/LAV; human immunodeficiency virus (HIV)] (7) (8) (9) . From in vitro studies, we and others have concluded that noninfectious preparations of either FeLV or HTLV-III viruses suppress several functions of feline or human lymphoid cells, respectively. For example, we showed that UV-inactivated FeLV (UV-FeLV) inhibits the production of a-T or y-interferon (11) by feline lymphocytes.
Pahwa et al. (12) showed that noninfectious band-purified preparations of HTLV-III inhibit proliferation of B lymphocytes activated by pokeweed mitogen (PWM), Staphylococcus aureus, or Epstein-Barr virus. Such preparations also inhibit T-cell proliferation induced by phytohemagglutinin, Con A, or allogeneic cells. Somewhat paradoxical was the finding that the same preparation of noninfectious HTLV-III, depending on experimental conditions, produced either polyclonal B-cell activation and activation of T cells to express Tac antigen or, in contrast, produced immunosuppressive effects. It would appear from such observations that virus preparations may contain protein(s) capable of multiple effects on lymphoid cell functions. Indeed, it has been established that the transmembrane envelope protein pl5E present in feline, murine, or bovine leukemia viruses, suppresses a number of lymphoid cell functions (13) (14) (15) (16) . Recently, Cianciolo et al. (17) synthesized a 17-amino acid peptide (CKS-17), which exhibits a striking homology to the transmembrane peptides present in many animal and human retroviruses (e.g., HTLV-I, HTLV-II, feline, murine, bovine, avian, and simian retroviruses) (18) (19) (20) . This peptide also suppresses in vitro the respiratory burst of human monocytes (21), interleukin 2-induced proliferation of an interleukin 2-dependent murine T-cell line, and proliferative reactions of human or murine lymphocytes in mixed lymphocyte cultures (17) . It also inhibits both endogenous and activated human natural killer cell lytic activity (22) .
In the present report, we demonstrate that viable FeLV or UV-FeLV may either activate or suppress immunoglobulin secretion by feline lymphocytes, depending on the concentration used. In contrast, the synthetic peptide CKS-17 produces only a potent inhibition of immunoglobulin secretion by activated feline lymphocytes.
MATERIALS AND METHODS
Animals. Domestic cats (five males and seven females) were obtained from the Department of Laboratory Animal Medicine (University of South Florida, Tampa, FL). They were periodically checked for the presence of FeLV by an enzyme-linked immunosorbent assay (Leukassay F; PitmanMoore, Washington Crossing, NJ) or by immunofluorescence as described (23) . Cats used in this study were nonviremic and appeared to be healthy.
Lymphocyte Preparations. Heparinized blood was obtained by venipuncture from the jugular vein of healthy cats. The peripheral blood lymphocytes (PBL) were separated from fresh blood by Ficoll-Hypaque (Pharmacia) density-gradient centrifugation. The PBL were washed three times with Hanks' balanced salt solution and resuspended in complete medium, RPMI 1640 medium supplemented with 15% heatinactivated fetal bovine serum/2 mM L-glutamine/penicillin (100 units/ml)/streptomycin (100 ,ug/ml) (GIBCO).
Viruses and CKS-17. Purified FeLV was provided by R. G. Olsen and L. E. Mathes (Ohio State University, Columbus, OH). Virus was inactivated by exposure to UV irradiation at a surface dose rate of 170 ergs'mm-2 sec-1 for an accumulated total of 1.5 x 106 ergs/mm2 according to the modified methods described (24, 25 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
was synthesized and purified as described (17) . As reported earlier (17, 21) , immunosuppressive activity is only seen when the peptide is coupled to the carrier protein bovine serum albumin (BSA). Previous studies using a series of partially homologous and nonhomologous retroviral peptides have demonstrated that only the CKS-17 peptide sequence has immunosuppressive activity (17, 21) . BSA that has undergone the coupling process in the absence of peptide as described (17, 21) was used as a control and is referred to as BSA*.
Cell Culture. Cat PBL were adjusted to 1 x 106 cells per ml in complete RPMI 1640 medium. The cells were dispensed in 0.5-ml volumes into plastic tubes (12 
RESULTS
Polyclonal B-Cell Activation by SPA or PWM Using Cat PBL. Fig. 1 shows that in the feline system, both PWM and SPA at optimal doses induce PFC response in the RHPA. SPA is, however, apparently a better inducer of IgG synthesis than PWM. Indeed, in some experiments when cells from different animals were used, PWM even suppressed formation of PFC, indicating that PWM may have activated suppressor cells (data not shown). Therefore, SPA was used in all subsequent experiments as an inducer of a PFC response in the RHPA.
Effect of Viable FeLV on Induction of IgG by Cat PBL. Fig.  2 presents the results ofthe RHPA in the presence or absence of different concentrations of viable FeLV (5, 10, or 40 ,g/ml) incubated with feline PBL in the presence or absence of SPA. As shown, the number of PFC increased significantly when FeLV at 5 ,g/ml (P < 0.0005) or 10 ,g/ml (P < 0.005) was added to the cat PBL. At a higher concentration (40 ,g/ml), induction of IgG was reduced. In contrast, when FeLV at the same concentrations used above was cultured with PBL plus SPA, a polyclonal activator of B cells, the SPA-induced PFC responses were inhibited significantly at 10 ,ug/ml (P < 0.005) or 40 ,ug/ml (P < 0. Effect of UV-FeLV on Polyclonal B-Cell Activation. As in the experiments described above, UV-FeLV also activated IgG production at low concentrations (P < 0.0005 at UV-FeLV of 5 ,g/ml and 10 ug/ml) and inhibited B-cell activation to immunoglobulin production by SPA at a higher concentration (P < 0.01 at UV-FeLV of 40 ,ug/ml; Fig. 3 ). It can be concluded from these two sets of experiments that whole virus, depending on the concentration, has a dual effect on B-cell activation. Furthermore, noninfective UV-inactivated viral particles are also effective, even though their ability to suppress polyclonal B-cell activation by SPA is less dramatic than when live virus is used.
Effect of Synthetic Peptide CKS-17 on Activation of B Cells. Retroviral-encoded CKS-17 gave the following results ( Fig.  4 ited SPA-induced immunoglobulin secretion in a dose-dependent fashion.
DISCUSSION
Our results are of interest from several points of view. Prior studies with human cells have shown that the reverse hemolytic plaque assay represents a useful method for estimating and evaluating polyclonal activation of B lymphocytes (28) (29) (30) . We showed that this system can also be adapted to cat cells using PWM as the stimulation (26) . SPA was found to induce even more consistent plaque formation with cells from numerous cats and was therefore used as a method of choice in polyclonal B-cell activation.
In the present studies, the biphasic effects of band-purified viable or UV-FeLV were illustrated by induction of differentiation of B lymphocytes at low concentrations, whereas higher concentrations cause inhibition of polyclonal B-cell activation by other activators such as SPA. These findings are remindful of the findings of Pahwa et al. (12) . These investigators showed that purified noninfectious preparations of HTLV-III/LAV (HIV), under conditions similar to those described here, could either induce proliferation of B cells at low dilutions of the virus preparations or inhibit polyclonal B-cell activation by several B cell activatorse.g., Staphylococcus aureus, Epstein-Barr virus, or PWM. These observations are also consonant with the observation that depressed humoral responses to T-cell-dependent or T-cell-independent antigens are frequently present in patients with acquired immunodeficiency syndrome (AIDS) despite the hypergammaglobulinemia that regularly accompanies this clinical condition (31, 32) .
The in vivo and in vitro immunosuppressive effects of retroviruses have been recognized for many years (1-9). Disrupted virus preparations or inactivated viruses produced by freeze-thawing (33) , Triton X-100 treatment (12, 34) , or UV irradiation (11, 35, 36) The results obtained in the present study suggest that different components of the virus may be responsible for the different abilities to suppress or activate lymphoid cells. They also suggest that CKS-17 represents an amino acid sequence that is crucial to some or all of the immunosuppressive actions attributable to the viruses or their piSE transmembrane components. It is of interest that cancer cell lines but not normal lymphoid cells have been shown to contain material immunologically reactive with epitopes present in pi5E (10, 13, 37) . If an immunosuppressive peptide homologous to CKS-17 is contained in and released by cancer cells, vital immunosuppressive effects of these cells might then be attributed to this peptide or a closely related cellular component (13) . The question of the origin, functions in the normal body economy, and perturbations in disease states of such a peptide might then become a most fundamental issue.
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